EDG2 (LPAR1) Human shRNA Plasmid Kit (Locus ID 1902)

Specifications

Product Data
Product Name	EDG2 (LPAR1) Human shRNA Plasmid Kit (Locus ID 1902)
Locus ID	1902
UniProt ID	Q92633
Synonyms	edg-2; EDG2; Gpcr26; LPA1; Mrec1.3; rec.1.3; vzg-1; VZG1
Vector	pGFP-V-RS
Format	Retroviral plasmids
Kit Components	LPAR1 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector(Gene ID = 1902). 5µg purified plasmid DNA per construct 29-mer scrambled shRNA cassette in pGFP-V-RS Vector, TR30013, included for free.
RefSeq	NM_001401, NM_057159, NM_001351397, NM_001351398, NM_001351399, NM_001351400, NM_001351401, NM_001351402, NM_001351403, NM_001351404, NM_001351405, NM_001351406, NM_001351407, NM_001351408, NM_001351409, NM_001351410, NM_001351411, NM_001351412, NM_001351413, NM_001351414, NM_001351415, NM_001351416, NM_001351417, NM_001351418, NM_001351419, NM_001351420, NM_001401.1, NM_001401.2, NM_001401.3, NM_057159.1, NM_057159.2, BC030615, BC030615.2, BC036034, BC036034.1, BC073167, NM_057159.4, NM_001401.5
Summary	The integral membrane protein encoded by this gene is a lysophosphatidic acid (LPA) receptor from a group known as EDG receptors. These receptors are members of the G protein-coupled receptor superfamily. Utilized by LPA for cell signaling, EDG receptors mediate diverse biologic functions, including proliferation, platelet aggregation, smooth muscle contraction, inhibition of neuroblastoma cell differentiation, chemotaxis, and tumor cell invasion. Many transcript variants encoding a few different isoforms have been identified for this gene. [provided by RefSeq, Oct 2020]
shRNA Design	These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service.
Performance Guaranteed	OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred).

*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.